NCT06279689

Brief Summary

This is a multi-center, exploratory, estimation study in both adult and pediatric populations. There is no investigational product injection during this study The exploratory objective of this study is to evaluate the anatomical characteristics of both anterolateral thighs in healthy adult and healthy pediatric populations (2 to 17 years old) by ultrasound scan before and while applying a force similar to the ZENEO® triggering force. In the healthy adult population, anatomical characteristics of one shoulder (deltoid) and one upper arm (biceps and triceps) will also be evaluated by ultrasound scan before and while applying a force similar to ZENEO® triggering force. Only ultrasound procedures will be performed using an investigational ultrasound system. All subjects will be asked to undergo 1 on site visit (Study Visit) during which the eligibility assessment and the ultrasound scans will be performed.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

February 13, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 28, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

July 22, 2024

Status Verified

July 1, 2024

Enrollment Period

7 months

First QC Date

January 31, 2024

Last Update Submit

July 19, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • STBD : Skin To Bone Distance

    Distance measurement

    Day1

  • STMD: Skin To Muscle Distance

    Distance measurement

    Day1

  • Thickness of skin layers (dermis, hypodermis)

    Thickness measurement

    Day1

  • Thickness of muscle layers

    Thickness measurement

    Day1

Secondary Outcomes (1)

  • Circumferences measurements (thigh, upper arm, waist, hip)

    Day1

Study Arms (1)

Healthy subjects : Adult and pediatric populations

EXPERIMENTAL

Only ultrasound procedures will be performed using an investigational ultrasound system. All subjects will be asked to undergo 1 on site visit (Study Visit) during which the eligibility assessment and the ultrasound scans will be performed is to evaluate the anatomical characteristics of both anterolateral thighs, one shoulder (deltoid) and one upper arm (biceps and triceps) before and while applying a force similar to the ZENEO® triggering force.

Other: Ultrasound scans

Interventions

Ultrasound scans connected with an application enabling the measurement of the force applied.

Healthy subjects : Adult and pediatric populations

Eligibility Criteria

Age2 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female, 2 to 70 years old, inclusive
  • In stable health, as determined by medical history and physical examination at screening (ie, any chronic medical diagnoses or conditions should be stable and well managed, with no significant changes expected during assessments, so that in the opinion of the investigator or designee there will not be any impact on the ability of the subject to participate in the study)
  • For the adult population, body mass index (BMI) ≥ 18.5 and ≤ 35 kg/m2 at screening BMI = weight (kg)/(height \[m\])2
  • Willing and able to provide written informed consent and assent (as appropriate) prior to initiation of study procedures
  • Subjects must be able to communicate effectively with the study staff and to understand study instructions (not applicable for toddlers and preschoolers)

You may not qualify if:

  • Any skin or muscular condition, such as eczema, scars, infections, moles, or tattoos at the site of measurements
  • Allergy to ultrasound gel
  • Any other condition or prior therapy that, in the investigator or designee's opinion, would make the subject unsuitable for the study, or unable or unwilling to comply with the study procedures
  • Is an employee or authorized representative of CROSSJECT SA or ICON plc
  • Adult under guardianship or subject incarcerated

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Trials of Texas, LLC dba Flourish Research

San Antonio, Texas, 78229, United States

RECRUITING

Study Officials

  • Nathalie LOUGHRAIEB

    Crossject

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2024

First Posted

February 28, 2024

Study Start

February 13, 2024

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

July 22, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations